The interleukin 1B-511 polymorphism is associated with the risk of developing restenosis after coronary stenting in Mexican patients

Human Immunology

Volumn 69, Issue 2, 2008, Pages 116-121

  Miranda Malpica, Emma ^a   Martínez Rios, Marco Antonio ^a   Fragoso, José Manuel ^a   Delgadillo Rodríguez, Hilda ^a   Rodríguez Pérez, José Manuel ^a   González Quesada, Carlos ^a   Martínez Rodríguez, Nancy ^a   Saldaña Mendoza, Arturo ^a   Peña Duque, Marco Antonio ^a   Vargas Alarcón, Gilberto ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

Coronary stenting; Genetic susceptibility; Interleukin 1; Polymorphisms; Restenosis

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; PHOSPHODIESTERASE I;

ADULT; AGED; ALLELE; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY STENT; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEXICO; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTENOSIS; RISK FACTOR;

AGED; BLOOD VESSEL PROSTHESIS IMPLANTATION; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; MALE; MEXICO; MIDDLE AGED; POLYMORPHISM, GENETIC; STENTS;

EID: 40849133988     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2007.12.003     Document Type: Article

References (32)

1. Murray C.J., and Lopez A.D. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 349 (1997) 1498
2. Weiczorek S.J., and Tsongalis G.J. Pharmacogenomics: will it change the field of medicine?. Clin Chim Acta 308 (2001) 1
3. Rapold H.J., David P.R., Guiteras Val P., Mata A.L., Crean P.A., and Bourassa M.G. Restenosis and its determinants in first and repeat coronary angioplasty. Eur Heart J 8 (1987) 575
4. Serruys P.W., de Jaegere P., Kiemeneij F., Macaya C., Rutsch W., Heyndrickx G., et al. A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 331 (1994) 489
5. Sigwart U., Puel J., Mirkovitch V., Joffre F., and Kappenberger L. Intravasculat stent to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 316 (1987) 701
6. Serruys P.W., van Hout B., Bonnier H., Legrand V., Garcia E., Macaya C., et al. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II). Lancet 352 (1998) 673
7. Mintz G.S., Popma J.J., Phicard A.D., Kent K.M., Satler L.F., Wong C., et al. Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation 94 (1996) 35
8. Kooemider M. Coronary stent implantation results in patients treated with ticlopidine and aspirin. Med Sci Monit 3 (1997) 821
9. Farb A., Sangiorgi G., Carter A.J., Walley V.M., Edwards W.D., Schwartz R.S., et al. Pathology of acute and chronic coronary stenting in humans. Circulation 99 (1999) 44
10. Ross R. Atherosclerosis and inflammatory disease. N Engl J Med 340 (1999) 115
11. Duff G.W. Cytokines and anti-cytokines. Br J Rheumatol 32 Suppl 1 (1993) 15
12. Arend W.P., Malyak M., Guthridge C.J., and Gabay C. Interleukin 1 receptor antagonist: role in biology. Annu Rev Immunol 16 (1998) 27
13. Libby P., Warner S.J., and Friedman G.B. Interleukin-1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. J Clin Invest 81 (1988) 487
14. di Giovine F.S., and Duff G.W. Interleukin 1: the first interleukin. Immunol Today 11 (1990) 13
15. Libby P., Schwartz D., Brogi E., Tanaka H., and Clinton S.K. A cascade model for restenosis: a special case of atherosclerosis progression. Circulation 86 Suppl III (1992) 47
16. Kornowski R., Hong M.K., Tio F.O., Bramwell O., Wu H., and Leon M.B. In stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 31 (1998) 224
17. Sims J.E., Nicklin M.J., Bazan J.F., Barton J.L., Busfield S.J., Ford J.E., et al. A new nomenclature for Il-1-family genes. Trends Immunol 22 (2001) 536
18. Nicklin M.J., Barton J.L., Nguyen M., FitzGerald M.G., Duff G.W., and Komman K. A sequence-based map of the nine genes of the human interleukin-1 cluster. Genomics 79 (2002) 718
19. Iacoviello L., Di Castelnuovo A., Gattone M., Pezzini A., Assanelli D., Lorenzet R., et al. Polymorphisms of the interleukin-1beta gene affect the risk of myocardial infarction and ischemic stroke at young age and the response of mononuclear cells to stimulation in vitro. Arterioscler Thromb Vasc Biol 25 (2005) 222
20. Latkovskis G., Licis N., and Kalnins U. C-reactive protein levels and common polymorphisms of the interleukin-1 gene cluster and interleukin-6 gene in patients with coronary heart disease. Eur J Immunogenet 31 (2004) 207
21. Auer J., Weber T., Berent R., Lassnig E., Lamm G., and Eber B. Genetic polymorphisms in cytokine and adhesion molecule genes in coronary artery disease. Am J Pharmacogenomics 3 (2003) 317
22. Miller A. A single salting out procedure for extraction DNA from human nucleated cell. Nucleic Acids Res 16 (1998) 1215
23. Timms A.E., Crane A.M., Sims A.M., Cordell H.J., Bradbury L.A., Abbott A., et al. The interleukin 1 gene cluster contains a major susceptibility locus for ankylosing spondylitis. Am J Hum Genet 75 (2004) 587
24. Tashiro H., Shimokawa H., Sadamatsu K., Aoki T., and Yamamoto K. Role of cytokines in the pathogenesis of restenosis after percutaneous transluminal coronary angioplasty. Coron Artery Dis 12 (2001) 107
25. Farb A., Weber D.K., Kolodgie F.D., Burke A.P., and Virmani R. Morphological predictors of restenosis after coronary stenting in humans. Circulation 105 (2002) 2974
26. Francis S.E., Camp N.J., Burton A.J., Dewberry R.M., Gunn J., Stephens-Lloyd A., et al. Interleukin 1 receptor antagonist gene polymorphism and restenosis after coronary angioplasty. Heart 86 (2001) 336
27. Volzke H., Grimm R., Robinson D.M., Wolff B., Schwahn C., Hertwig S., et al. Candidate genetic markers and the risk of restenosis after coronary angioplasty. Clin Sci (Lond) 106 (2004) 35
28. Kastrati A., Koch W., Berger P.B., Mehilli J., Stephenson K., Neumann F.J., et al. Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting. J Am Coll Cardiol 36 (2000) 2168
29. Zee R.Y., Fernandez-Ortiz A., Macaya C., Pintor E., Fernandez-Cruz A., and Lindpaintner K. IL-1 cluster genes and occurrence of post-percutaneous transluminal coronary angioplasty restenosis: a prospective, angiography-based evaluation. Atherosclerosis 171 (2003) 259
30. Vohnout B., Di Castelnuovo A., Trotta R., D'Orazi A., Panniteri G., Montali A., et al. Interleukin-1 gene cluster polymorphisms and risk of coronary artery disease. Haematologica 88 (2003) 54
31. Marculescu R., Mlekusch W., Exner M., Sabeti S., Michor S., Rumpold H., et al. Interleukin-1 cluster combined genotype and restenosis after balloon angioplasty. Thromb Haemost 90 (2003) 491
32. Licker R., Ramirez E., Briceño R.P., Granados J., and Babinsky V. Gene frequencies and admixture estimates in four Mexican Urban Centers. Hum Biol 62 (1990) 791